BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26828330)

  • 1. Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.
    DeWitt JC; Germolec DR; Luebke RW; Johnson VJ
    Curr Protoc Toxicol; 2016 Feb; 67(1):18.1.1-18.1.22. PubMed ID: 26828330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental studies on immunosuppression: how do they predict for man?
    Vos JG; Van Loveren H
    Toxicology; 1998 Aug; 129(1):13-26. PubMed ID: 9769107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotoxicity and pathogenicity of substances].
    van den Tweel JG
    Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1949-51. PubMed ID: 1407175
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiology studies in immunotoxicity evaluations.
    Biagini RE
    Toxicology; 1998 Aug; 129(1):37-54. PubMed ID: 9769109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The skin: target organ in immunotoxicology of small-molecular-weight compounds.
    Merk HF; Sachs B; Baron J
    Skin Pharmacol Appl Skin Physiol; 2001; 14(6):419-30. PubMed ID: 11598442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotoxicity: the risk is real.
    Selgrade MK
    Toxicol Sci; 2007 Dec; 100(2):328-32. PubMed ID: 17878151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxicology: opportunities for non-animal test development.
    Corsini E; Roggen EL
    Altern Lab Anim; 2009 Sep; 37(4):387-97. PubMed ID: 19807211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotoxicology: review of current status.
    Luster MI; Germolec DR; Rosenthal GJ
    Ann Allergy; 1990 May; 64(5):427-32. PubMed ID: 2186671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxicology and its application in risk assessment.
    Rooney AA; Luebke RW; Selgrade MK; Germolec DR
    Exp Suppl; 2012; 101():251-87. PubMed ID: 22945572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune system as a target for chemical toxicity.
    Revillard JP
    Eur Cytokine Netw; 1991; 2(2):81-7. PubMed ID: 1813018
    [No Abstract]   [Full Text] [Related]  

  • 11. Can infections protect against autoimmunity?
    Gaisford W; Cooke A
    Curr Opin Rheumatol; 2009 Jul; 21(4):391-6. PubMed ID: 19412105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodologies for developmental immunotoxicity (DIT) testing.
    Dietert RR; Holsapple MP
    Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer.
    Dietert RR
    Reprod Toxicol; 2011 Apr; 31(3):319-26. PubMed ID: 20854896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ICH S8 immunotoxicity guidance. Immune function assessment and toxicological pathology: autonomous or synergistic methods to predict immunotoxicity?
    Spanhaak S
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):373-6. PubMed ID: 16723215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of the immune system to injury.
    Descotes J; Choquet-Kastylevsky G; Van Ganse E; Vial T
    Toxicol Pathol; 2000; 28(3):479-81. PubMed ID: 10862568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associating changes in the immune system with clinical diseases for interpretation in risk assessment.
    Luster MI; Germolec DR; Parks CG; Blaciforti L; Kashon M; Luebke R
    Curr Protoc Toxicol; 2004; Chapter 18(1):Unit18.1. PubMed ID: 23045101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring infections in non-human primates (NHP) and immunotoxicity implications: discussion sessions.
    Olivier KJ; Price KD; Hutto DL; Lerche NW; Mansfield KG; Simmons JH; Taylor K; Myers LP; Ouyang Y; Evans EW
    J Immunotoxicol; 2010; 7(2):138-46. PubMed ID: 20441554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of T-helper cell populations: potential mechanisms of respiratory hypersensitivity and immune suppression.
    Selgrade MK; Lawrence DA; Ullrich SE; Gilmour MI; Schuyler MR; Kimber I
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):218-29. PubMed ID: 9221840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of xenobiotics for direct immunotoxicity in an animal study.
    De Jong WH; Van Loveren H
    Methods; 2007 Jan; 41(1):3-8. PubMed ID: 17161297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of immunotoxicity using precision-cut tissue slices.
    Sewald K; Braun A
    Xenobiotica; 2013 Jan; 43(1):84-97. PubMed ID: 23199366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.